Atlas Trials

A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes

Clinical trial NCT00312130 · COMPLETED

Trial details

NCT number
NCT00312130
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pre-diabetes
Start date
2005-04-01
Primary completion
2006-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.